EUVIMEDEUVIMED entdecken
Open Access

Semisynthesis of bersavine and berbamine derivatives that target the CaMKIIγ:cMyc axis for lymphoma therapy

Berkley Lujan, Mingfeng Zhang, Yujie Cao, Arnav Kacker, Lina Mai, Shunquan Wu, Taylor Alexander, Wendong Huang, Kevin G M Kou iD

Organic & Biomolecular Chemistry · 2025

DOI: 10.1039/d5ob00310e ↗

Kurz gefasst

Fachartikel in der Zeitschrift Organic & Biomolecular Chemistry, 2025. Verfasst von Berkley Lujan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of California, Riverside, California 92507, USA. kevin.kou@ucr.edu. Hauptthemen laut MEDLINE: Benzylisoquinolines, Lymphoma, Calcium-Calmodulin-Dependent Protein Kinase Type 2, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bersavine, a bisbenzylisoquinoline alkaloid (bisBIA), and its derivatives are promising leads for developing novel therapeutics to treat aggressive cancers such as lymphoma, by targeting the CaMKIIγ:cMyc axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzylisoquinolinesLymphomaCalcium-Calmodulin-Dependent Protein Kinase Type 2Antineoplastic AgentsProto-Oncogene Proteins c-mycProtein Kinase InhibitorsHumansStructure-Activity RelationshipMolecular Docking SimulationCell Line, TumorDrug Screening Assays, AntitumorMolecular StructureCell ProliferationDose-Response Relationship, Drug

Substanzen

BenzylisoquinolinesberbamineCalcium-Calmodulin-Dependent Protein Kinase Type 2Antineoplastic AgentsProto-Oncogene Proteins c-mycProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry, University of California, Riverside, California 92507, USA. kevin.kou@ucr.edu.
  • Department of Diabetes Complications & Metabolism Research, City of Hope National Medical Center, Duarte, California 91010, USA.
  • Kyowa Kirin, Inc., 9420 Athena Cir, La Jolla, CA 92037, USA.

ORCID-Profile: Kevin G M Kou

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health
  • National Science Foundation

Zitieren

APA

Lujan, B., Zhang, M., Cao, Y., Kacker, A., Mai, L., Wu, S., Alexander, T., Huang, W., & Kou, K. G. M. (2025). Semisynthesis of bersavine and berbamine derivatives that target the CaMKIIγ:cMyc axis for lymphoma therapy. Organic & Biomolecular Chemistry. https://doi.org/10.1039/d5ob00310e

Vancouver

Lujan B, Zhang M, Cao Y, Kacker A, Mai L, Wu S, et al. Semisynthesis of bersavine and berbamine derivatives that target the CaMKIIγ:cMyc axis for lymphoma therapy. Organic & Biomolecular Chemistry. 2025. doi:10.1039/d5ob00310e

BibTeX
@article{Lujan2025,
  author = {Lujan, Berkley and Zhang, Mingfeng and Cao, Yujie and Kacker, Arnav and Mai, Lina and Wu, Shunquan and Alexander, Taylor and Huang, Wendong and Kou, Kevin G M},
  title = {Semisynthesis of bersavine and berbamine derivatives that target the CaMKIIγ:cMyc axis for lymphoma therapy},
  journal = {Organic & Biomolecular Chemistry},
  year = {2025},
  doi = {10.1039/d5ob00310e}
}
Kostenlos starten →